Avita Medical Ltd (RCEL)

[Billr05]

Old Mission Capital Buys 1.3% of Avita Therapeutics Inc.
By Bloomberg Automation

(Bloomberg) -- Old Mission Capital took a new position in Avita Therapeutics Inc. in the second quarter, buying 1.3 percent of the company's outstanding stock.

For the company's full holders list, click here.
The brokerage bought 269,579 shares with a current market value of $6.48 million, according to its 13F filing with the Securities and Exchange Commission.

Old Mission Capital LLC initiated 49 other positions in the health care sector during the quarter, bringing its total to 54 companies. At the end of the quarter, they comprised 7.8 percent, or $109 million, of the brokerage's total equity holdings of $1.39 billion disclosed in the 13F.
Avita Therapeutics traded at $24.03, down 47 percent year to date.

Bloomberg analyzed more than 4,300 institutional investors that are required to disclose their U.S. equity investments to the Securities and Exchange Commission each quarter. An algorithm searched for investors that had reported purchasing at least 1 percent of a company's shares in its latest filing and showed no holdings in the stock in the previous filing.

To see investor's holdings, click here.
RCEL US Equity
Graphic Dashboard»
Related ticker:
RCEL US (Avita Therapeutics Inc)
To contact Bloomberg News for this story:
[phone] or [e-mail] story was produced by Bloomberg Automation.